Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sue‐Jane Wang
Observed names:
Sue Jane Wang,
Sue-Jane Wang
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
Cedars-Sinai Medical Center,
National Institutes of Health,
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Memorial Sloan Kettering Cancer Center,
Johns Hopkins University,
Wyeth
show all 7
ORCID:
0000-0003-3054-0334
Observed ORCID:
0000-0003-3054-0334
OpenAlex ID:
A5074536742
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
2006
·
Leming Shi
, Leming Shi
, et al.
·
Nature Biotechnology
·
2,286
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
2010
·
Leming Shi
, Zhining Wen
, et al.
·
Nature Biotechnology
·
969
Modification of Sample Size in Group Sequential Clinical Trials
1999
·
Lu Cui
, H. M. James Hung
, et al.
·
Biometrics
·
604
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies
2008
·
Leming Shi
, Wendell D Jones
, et al.
·
BMC Bioinformatics
·
421
PDF
Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset
2007
·
Sue‐Jane Wang
, Robert T. O'Neill
, et al.
·
Pharmaceutical Statistics
·
274
Vilazodone: Clinical Basis for the US Food and Drug Administration’s Approval of a New Antidepressant
2011
·
Thomas P. Laughren
, Jogarao Gobburu
, et al.
·
The Journal of Clinical Psychiatry
·
233
Some fundamental issues with non‐inferiority testing in active controlled trials
2002
·
H. M. James Hung
, Sue‐Jane Wang
, et al.
·
Statistics in Medicine
·
212
A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2
2017
·
Wentian Guo
, Sue-Jane Wang
, et al.
·
Contemporary Clinical Trials
·
144
PDF
A Regulatory Perspective on Choice of Margin and Statistical Inference Issue in Non‐inferiority Trials
2005
·
H. M. James Hung
, Sue‐Jane Wang
, et al.
·
Biometrical Journal
·
124
Evaluation of external RNA controls for the assessment of microarray performance
2006
·
Weida Tong
, Anne Bergstrom Lucas
, et al.
·
Nature Biotechnology
·
116
Increased risk for type I (insulin‐dependent) diabetes in relatives of patients with alopecia areata (AA)
1994
·
Sue‐Jane Wang
, Tamar Shohat
, et al.
·
American Journal of Medical Genetics
·
103
Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials
2011
·
Yeh-Fong Chen
, Yang Yang
, et al.
·
Contemporary Clinical Trials
·
90
Utility and pitfalls of some statistical methods in active controlled clinical trials
2002
·
Sue-Jane Wang
, H.M.James Hung
, et al.
·
Controlled Clinical Trials
·
84
Issues Related to Subgroup Analysis in Clinical Trials
2002
·
Lu Cui
, H. M. James Hung
, et al.
·
Journal of Biopharmaceutical Statistics
·
83
Group sequential test strategies for superiority and non‐inferiority hypotheses in active controlled clinical trials
2001
·
Sue‐Jane Wang
, H. M. James Hung
, et al.
·
Statistics in Medicine
·
82
Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials
2007
·
H. M. James Hung
, Sue-Jane Wang
, et al.
·
Journal of Biopharmaceutical Statistics
·
81
A Regulatory View on Adaptive/Flexible Clinical Trial Design
2006
·
H. M. James Hung
, Robert T. O'Neill
, et al.
·
Biometrical Journal
·
76
Adapting the sample size planning of a phase III trial based on phase II data
2006
·
Sue‐Jane Wang
, H. M. James Hung
, et al.
·
Pharmaceutical Statistics
·
74
PDF
Consideration of regional difference in design and analysis of multi‐regional trials
2010
·
H. M. James Hung
, Sue‐Jane Wang
, et al.
·
Pharmaceutical Statistics
·
69
Challenges and regulatory experiences with non‐inferiority trial design without placebo arm
2009
·
H. M. James Hung
, Sue‐Jane Wang
, et al.
·
Biometrical Journal
·
52
Statistical Issues On Objective, Design, And Analysis Of Noninferiority Active-controlled Clinical Trial
2003
·
Yi Tsong
, Sue Jane Wang
, et al.
·
Journal of Biopharmaceutical Statistics
·
44
TACT method for non‐inferiority testing in active controlled trials
2002
·
Sue‐Jane Wang
, H. M. James Hung
·
Statistics in Medicine
·
44
Challenges to multiple testing in clinical trials
2010
·
H. M. James Hung
, Sue‐Jane Wang
·
Biometrical Journal
·
39
Sample Size for Identifying Differentially Expressed Genes in Microarray Experiments
2004
·
Sue-Jane Wang
, James J. Chen
·
Journal of Computational Biology
·
38
Assessing treatment efficacy in noninferiority trials
2003
·
Sue-Jane Wang
, H.M.James Hung
·
Controlled Clinical Trials
·
37
Show more works
View as search
Works count:
111
Citation count:
7,251
H-index:
31
I10-index:
61
Year
Topic
Type